INmune Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.
CEODavid J. Moss
CEODavid J. Moss
Employees22
Employees22
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2015
Founded2015
Employees22
Employees22
INMB Key Statistics
Market cap40.81M
Market cap40.81M
Price-Earnings ratio-0.72
Price-Earnings ratio-0.72
Dividend yield—
Dividend yield—
Average volume399.83K
Average volume399.83K
High today$1.70
High today$1.70
Low today$1.53
Low today$1.53
Open price$1.62
Open price$1.62
Volume467.33K
Volume467.33K
52 Week high$11.64
52 Week high$11.64
52 Week low$1.38
52 Week low$1.38
Stock Snapshot
With a market cap of 40.81M, INmune Bio(INMB) trades at $1.53. The stock has a price-to-earnings ratio of -0.72.
On 2026-01-05, INmune Bio(INMB) stock traded between a low of $1.53 and a high of $1.70. Shares are currently priced at $1.53, which is +0.0% above the low and -10.0% below the high.
INmune Bio(INMB) shares are trading with a volume of 467.33K, against a daily average of 399.83K.
In the last year, INmune Bio(INMB) shares hit a 52-week high of $11.64 and a 52-week low of $1.38.
In the last year, INmune Bio(INMB) shares hit a 52-week high of $11.64 and a 52-week low of $1.38.
People also own
Based on the portfolios of people who own INMB. This list is generated using Robinhood data, and it’s not a recommendation.